On April 22, 2025, Mark D. Stolper notified Coherus BioSciences, Inc. that he will not stand for re-election to the Board, effective at the 2025 Annual Meeting; he will continue as a consultant until December 31, 2026. The Board also realigned its member classifications to ensure balance among classes of directors.